Article
Therapeutic trends in pancreatic ductal adenocarcinoma (PDAC)
12 Dec 2018
Abstract excerpt
INTRODUCTION: Prognosis remains dismal for pancreatic ductal adenocarcinoma (PDAC). Genomics and proteomics have depicted heterogeneity in PDAC. Collectively, this information could be useful in improving diagnosis, prognosis, modalities of therapy, treatment responses, deciphering drug resistance and new drug development. AREAS COVERED: We describe major advances in the cellular and molecular subtypes based on...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
